| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sulfate adenylyltransferase (ATP) activity | 1.32e-05 | 2 | 73 | 2 | GO:0004781 | |
| GeneOntologyMolecularFunction | sulfate adenylyltransferase activity | 1.32e-05 | 2 | 73 | 2 | GO:0004779 | |
| GeneOntologyMolecularFunction | adenylylsulfate kinase activity | 1.32e-05 | 2 | 73 | 2 | GO:0004020 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate kinase activity | 5.95e-05 | 21 | 73 | 3 | GO:0004550 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 1.31e-04 | 5 | 73 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.96e-04 | 31 | 73 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 3.64e-04 | 8 | 73 | 2 | GO:0098821 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 3.64e-04 | 8 | 73 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 3.64e-04 | 8 | 73 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, phosphate group as acceptor | 4.52e-04 | 41 | 73 | 3 | GO:0016776 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound kinase activity | 6.77e-04 | 47 | 73 | 3 | GO:0019205 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 9.11e-04 | 52 | 73 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.00e-03 | 13 | 73 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | glycine binding | 1.17e-03 | 14 | 73 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | glutamate binding | 1.17e-03 | 14 | 73 | 2 | GO:0016595 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 1.34e-03 | 15 | 73 | 2 | GO:0019215 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.73e-03 | 17 | 73 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 1.83e-03 | 239 | 73 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 2.38e-03 | 254 | 73 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 2.40e-03 | 20 | 73 | 2 | GO:0004675 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.82e-03 | 77 | 73 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | BMP binding | 2.90e-03 | 22 | 73 | 2 | GO:0036122 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 3.26e-03 | 81 | 73 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.45e-03 | 24 | 73 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ZCCHC9 FN1 P2RX4 LOXL2 WT1 CYP4F2 GRIN2B ZNF385C AGBL2 AGBL3 VAT1 | 3.78e-03 | 1189 | 73 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | glutamate receptor activity | 4.36e-03 | 27 | 73 | 2 | GO:0008066 | |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 5.80e-06 | 11 | 69 | 3 | GO:0006228 | |
| GeneOntologyBiologicalProcess | GTP biosynthetic process | 1.00e-05 | 13 | 69 | 3 | GO:0006183 | |
| GeneOntologyBiologicalProcess | UTP metabolic process | 1.00e-05 | 13 | 69 | 3 | GO:0046051 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process | 1.10e-05 | 2 | 69 | 2 | GO:0050428 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate biosynthetic process | 1.10e-05 | 2 | 69 | 2 | GO:0034036 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 1.24e-05 | 232 | 69 | 7 | GO:0009152 | |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 1.58e-05 | 15 | 69 | 3 | GO:0006241 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 1.86e-05 | 247 | 69 | 7 | GO:0009260 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 1.94e-05 | 16 | 69 | 3 | GO:0009209 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 2.17e-05 | 253 | 69 | 7 | GO:0046390 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 2.36e-05 | 17 | 69 | 3 | GO:0046036 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate metabolic process | 3.34e-05 | 19 | 69 | 3 | GO:0009208 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate biosynthetic process | 3.92e-05 | 20 | 69 | 3 | GO:0009148 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 4.14e-05 | 280 | 69 | 7 | GO:0006164 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 4.95e-05 | 288 | 69 | 7 | GO:0072522 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate biosynthetic process | 5.18e-05 | 61 | 69 | 4 | GO:0033866 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate biosynthetic process | 5.18e-05 | 61 | 69 | 4 | GO:0034030 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate biosynthetic process | 5.18e-05 | 61 | 69 | 4 | GO:0034033 | |
| GeneOntologyBiologicalProcess | sulfate assimilation | 6.59e-05 | 4 | 69 | 2 | GO:0000103 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 6.66e-05 | 65 | 69 | 4 | GO:0098815 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 7.49e-05 | 130 | 69 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 7.82e-05 | 25 | 69 | 3 | GO:0009220 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside triphosphate metabolic process | 7.82e-05 | 25 | 69 | 3 | GO:0009147 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 9.41e-05 | 319 | 69 | 7 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 9.59e-05 | 320 | 69 | 7 | GO:1901293 | |
| GeneOntologyBiologicalProcess | GTP metabolic process | 1.23e-04 | 29 | 69 | 3 | GO:0046039 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.34e-04 | 147 | 69 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | TMTC1 BMPR1B ACACA ACLY NME2P1 NME1 NME2 PAPSS2 PAPSS1 CEMIP | 1.60e-04 | 736 | 69 | 10 | GO:1901137 |
| GeneOntologyBiologicalProcess | protein side chain deglutamylation | 1.64e-04 | 6 | 69 | 2 | GO:0035610 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 1.82e-04 | 33 | 69 | 3 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 1.99e-04 | 34 | 69 | 3 | GO:0009218 | |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 2.29e-04 | 7 | 69 | 2 | GO:0006231 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 2.29e-04 | 7 | 69 | 2 | GO:0009177 | |
| GeneOntologyBiologicalProcess | protein deglutamylation | 3.05e-04 | 8 | 69 | 2 | GO:0035608 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 3.43e-04 | 180 | 69 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound biosynthetic process | 4.02e-04 | 43 | 69 | 3 | GO:0072528 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 4.02e-04 | 43 | 69 | 3 | GO:2000463 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 4.60e-04 | 192 | 69 | 5 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 4.84e-04 | 846 | 69 | 10 | GO:0120035 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 5.66e-04 | 863 | 69 | 10 | GO:0031344 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.88e-04 | 566 | 69 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide biosynthetic process | 5.95e-04 | 11 | 69 | 2 | GO:0009221 | |
| GeneOntologyBiologicalProcess | deoxyribonucleoside monophosphate biosynthetic process | 7.12e-04 | 12 | 69 | 2 | GO:0009157 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide metabolic process | 8.30e-04 | 55 | 69 | 3 | GO:0006220 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization to cell surface | 8.40e-04 | 13 | 69 | 2 | GO:2000009 | |
| GeneOntologyBiologicalProcess | dTMP metabolic process | 9.78e-04 | 14 | 69 | 2 | GO:0046073 | |
| GeneOntologyCellularComponent | dendritic branch | 2.50e-04 | 7 | 73 | 2 | GO:0044307 | |
| GeneOntologyCellularComponent | HFE-transferrin receptor complex | 3.32e-04 | 8 | 73 | 2 | GO:1990712 | |
| GeneOntologyCellularComponent | terminal bouton | 3.57e-04 | 96 | 73 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 4.26e-04 | 9 | 73 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 4.56e-04 | 43 | 73 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | secretory granule lumen | 9.57e-04 | 325 | 73 | 6 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 1.04e-03 | 330 | 73 | 6 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 1.07e-03 | 332 | 73 | 6 | GO:0031983 | |
| GeneOntologyCellularComponent | pseudopodium | 1.77e-03 | 18 | 73 | 2 | GO:0031143 | |
| MousePheno | absence of NMDA-mediated synaptic currents | 1.41e-05 | 2 | 53 | 2 | MP:0001901 | |
| Domain | NDP_KINASES | 4.73e-06 | 9 | 73 | 3 | PS00469 | |
| Domain | NDK | 6.74e-06 | 10 | 73 | 3 | SM00562 | |
| Domain | NDK | 6.74e-06 | 10 | 73 | 3 | PF00334 | |
| Domain | Nucleoside_diP_kinase | 1.23e-05 | 12 | 73 | 3 | IPR001564 | |
| Domain | APS_kinase | 1.51e-05 | 2 | 73 | 2 | IPR002891 | |
| Domain | Sulphate_adenylyltransferase | 1.51e-05 | 2 | 73 | 2 | IPR002650 | |
| Domain | ATP-Sase_PUA-like_dom | 1.51e-05 | 2 | 73 | 2 | IPR025980 | |
| Domain | Sulfurylase_cat_dom | 1.51e-05 | 2 | 73 | 2 | IPR024951 | |
| Domain | ATP-sulfurylase | 1.51e-05 | 2 | 73 | 2 | PF01747 | |
| Domain | PUA_2 | 1.51e-05 | 2 | 73 | 2 | PF14306 | |
| Domain | G_patch | 9.59e-05 | 23 | 73 | 3 | SM00443 | |
| Domain | G_patch_dom | 9.59e-05 | 23 | 73 | 3 | IPR000467 | |
| Domain | G_PATCH | 9.59e-05 | 23 | 73 | 3 | PS50174 | |
| Domain | G-patch | 9.59e-05 | 23 | 73 | 3 | PF01585 | |
| Domain | Nucleoside_diP_kinase_AS | 1.50e-04 | 5 | 73 | 2 | IPR023005 | |
| Domain | Spectrin_repeat | 1.95e-04 | 29 | 73 | 3 | IPR002017 | |
| Domain | FAT | 2.24e-04 | 6 | 73 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 2.24e-04 | 6 | 73 | 2 | IPR003151 | |
| Domain | Spectrin/alpha-actinin | 2.62e-04 | 32 | 73 | 3 | IPR018159 | |
| Domain | SPEC | 2.62e-04 | 32 | 73 | 3 | SM00150 | |
| Domain | GS | 3.12e-04 | 7 | 73 | 2 | SM00467 | |
| Domain | GS_dom | 3.12e-04 | 7 | 73 | 2 | IPR003605 | |
| Domain | GS | 3.12e-04 | 7 | 73 | 2 | PS51256 | |
| Domain | TGF_beta_GS | 3.12e-04 | 7 | 73 | 2 | PF08515 | |
| Domain | Activin_recp | 6.64e-04 | 10 | 73 | 2 | IPR000472 | |
| Domain | - | 6.64e-04 | 10 | 73 | 2 | 4.10.1060.10 | |
| Domain | Activin_recp | 6.64e-04 | 10 | 73 | 2 | PF01064 | |
| Domain | TGFB_receptor | 9.70e-04 | 12 | 73 | 2 | IPR000333 | |
| Domain | Iontro_rcpt | 2.21e-03 | 18 | 73 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.21e-03 | 18 | 73 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 2.21e-03 | 18 | 73 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.21e-03 | 18 | 73 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.21e-03 | 18 | 73 | 2 | SM00918 | |
| Domain | Lig_chan | 2.21e-03 | 18 | 73 | 2 | PF00060 | |
| Domain | PBPe | 2.21e-03 | 18 | 73 | 2 | SM00079 | |
| Domain | - | 2.21e-03 | 18 | 73 | 2 | 3.30.470.20 | |
| Domain | PUA-like_domain | 2.47e-03 | 19 | 73 | 2 | IPR015947 | |
| Domain | zf-RanBP | 3.31e-03 | 22 | 73 | 2 | PF00641 | |
| Domain | Actinin_actin-bd_CS | 3.61e-03 | 23 | 73 | 2 | IPR001589 | |
| Domain | ZnF_RBZ | 3.61e-03 | 23 | 73 | 2 | SM00547 | |
| Domain | Peptidase_M14 | 3.61e-03 | 23 | 73 | 2 | PF00246 | |
| Domain | Spectrin | 3.61e-03 | 23 | 73 | 2 | PF00435 | |
| Domain | ZF_RANBP2_2 | 3.61e-03 | 23 | 73 | 2 | PS50199 | |
| Domain | Peptidase_M14 | 3.61e-03 | 23 | 73 | 2 | IPR000834 | |
| Domain | ACTININ_2 | 3.61e-03 | 23 | 73 | 2 | PS00020 | |
| Domain | ACTININ_1 | 3.61e-03 | 23 | 73 | 2 | PS00019 | |
| Domain | ZF_RANBP2_1 | 3.93e-03 | 24 | 73 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 4.26e-03 | 25 | 73 | 2 | IPR001876 | |
| Domain | ATP_grasp_subdomain_2 | 6.51e-03 | 31 | 73 | 2 | IPR013816 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 6.45e-05 | 20 | 56 | 3 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 7.51e-05 | 21 | 56 | 3 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 7.51e-05 | 21 | 56 | 3 | M27944 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 9.94e-05 | 23 | 56 | 3 | M27949 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 1.54e-04 | 5 | 56 | 2 | M47667 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.81e-04 | 28 | 56 | 3 | M837 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 2.30e-04 | 6 | 56 | 2 | M47668 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 2.30e-04 | 6 | 56 | 2 | MM14679 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 2.30e-04 | 6 | 56 | 2 | M27027 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 4.27e-04 | 8 | 56 | 2 | M26991 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47844 | |
| Pathway | PID_BMP_PATHWAY | 6.11e-04 | 42 | 56 | 3 | M181 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.01e-04 | 44 | 56 | 3 | M27934 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 8.33e-04 | 11 | 56 | 2 | M46429 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 8.51e-04 | 47 | 56 | 3 | M39531 | |
| Pathway | WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION | 9.97e-04 | 12 | 56 | 2 | M39519 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 9.97e-04 | 12 | 56 | 2 | MM16638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL | 9.97e-04 | 12 | 56 | 2 | M47953 | |
| Pathway | KEGG_SULFUR_METABOLISM | 1.18e-03 | 13 | 56 | 2 | M18256 | |
| Pubmed | 9.25e-09 | 3 | 74 | 3 | 8270257 | ||
| Pubmed | Competitive binding of alpha-actinin and calmodulin to the NMDA receptor. | 9.22e-08 | 5 | 74 | 3 | 9009191 | |
| Pubmed | NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. | 7.70e-07 | 9 | 74 | 3 | 16710293 | |
| Pubmed | 2.01e-06 | 12 | 74 | 3 | 8615909 | ||
| Pubmed | 2.01e-06 | 12 | 74 | 3 | 8665664 | ||
| Pubmed | 2.01e-06 | 12 | 74 | 3 | 12815021 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FN1 P2RX4 ACLY CAPN7 ZG16B NME2P1 ACTN2 MINPP1 NME1 NME2 CNP VAT1 | 2.56e-06 | 1070 | 74 | 12 | 23533145 |
| Pubmed | Bmp in podocytes is essential for normal glomerular capillary formation. | 3.31e-06 | 14 | 74 | 3 | 18272846 | |
| Pubmed | 3.31e-06 | 14 | 74 | 3 | 10373510 | ||
| Pubmed | Conservation of notochord gene expression across chordates: insights from the Leprecan gene family. | 3.31e-06 | 14 | 74 | 3 | 18798549 | |
| Pubmed | 4.12e-06 | 197 | 74 | 6 | 36604605 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 4.13e-06 | 15 | 74 | 3 | 14622581 | |
| Pubmed | 4.13e-06 | 15 | 74 | 3 | 9481670 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19095845 | ||
| Pubmed | A member of a family of sulfate-activating enzymes causes murine brachymorphism. | 4.47e-06 | 2 | 74 | 2 | 9671738 | |
| Pubmed | Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells. | 4.47e-06 | 2 | 74 | 2 | 21597037 | |
| Pubmed | Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis. | 4.47e-06 | 2 | 74 | 2 | 23840674 | |
| Pubmed | Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. | 4.47e-06 | 2 | 74 | 2 | 2509941 | |
| Pubmed | Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans. | 4.47e-06 | 2 | 74 | 2 | 21753020 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15328026 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28662214 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15102710 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19784770 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9730621 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 31759052 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10850425 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28357470 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12200143 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15841096 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 21085602 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19487695 | ||
| Pubmed | Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. | 4.47e-06 | 2 | 74 | 2 | 35259022 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 7488060 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 8245015 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12007505 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28586478 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 15322331 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12972261 | ||
| Pubmed | Overlapping cortical malformations in patients with pathogenic variants in GRIN1 and GRIN2B. | 4.47e-06 | 2 | 74 | 2 | 35393335 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10657990 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 30504838 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26819771 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 10679223 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26041915 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 16289038 | ||
| Pubmed | Computationally Discovered Potentiating Role of Glycans on NMDA Receptors. | 4.47e-06 | 2 | 74 | 2 | 28378791 | |
| Pubmed | Redox regulation of neuronal migration in a Down Syndrome model. | 4.47e-06 | 2 | 74 | 2 | 12957649 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 22711533 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 25450957 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 9771708 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20438806 | ||
| Pubmed | BMPR1A and BMPR1B Missense Mutations Cause Primary Ovarian Insufficiency. | 4.47e-06 | 2 | 74 | 2 | 31769494 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 11931637 | ||
| Pubmed | Role of WT1-ZNF224 interaction in the expression of apoptosis-regulating genes. | 4.47e-06 | 2 | 74 | 2 | 23362234 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 36639372 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 23886516 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 32764110 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 14573320 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 34111520 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20673479 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 20591825 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 26320177 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19224577 | ||
| Pubmed | Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis. | 4.47e-06 | 2 | 74 | 2 | 25431428 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28283559 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 12239212 | ||
| Pubmed | Ion permeation properties of the cloned mouse epsilon 2/zeta 1 NMDA receptor channel. | 4.47e-06 | 2 | 74 | 2 | 7531804 | |
| Pubmed | The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. | 4.47e-06 | 2 | 74 | 2 | 32392889 | |
| Pubmed | Effects of cocaine-kindling on the expression of NMDA receptors and glutamate levels in mouse brain. | 4.47e-06 | 2 | 74 | 2 | 20927585 | |
| Pubmed | Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1. | 4.47e-06 | 2 | 74 | 2 | 18470881 | |
| Pubmed | Human PAPS synthase isoforms are dynamically regulated enzymes with access to nucleus and cytoplasm. | 4.47e-06 | 2 | 74 | 2 | 22242175 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18068304 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 19446010 | ||
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 28228639 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 8.05e-06 | 807 | 74 | 10 | 30575818 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.02e-05 | 231 | 74 | 6 | 16452087 | |
| Pubmed | 1.03e-05 | 20 | 74 | 3 | 29483282 | ||
| Pubmed | 1.03e-05 | 20 | 74 | 3 | 16635246 | ||
| Pubmed | 1.03e-05 | 20 | 74 | 3 | 12743021 | ||
| Pubmed | Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism. | 1.34e-05 | 3 | 74 | 2 | 27292539 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 11897110 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 10480938 | ||
| Pubmed | Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? | 1.34e-05 | 3 | 74 | 2 | 14499630 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30352630 | ||
| Pubmed | Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line. | 1.34e-05 | 3 | 74 | 2 | 15897891 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 38836461 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 37000222 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 19805292 | ||
| Pubmed | Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans. | 1.34e-05 | 3 | 74 | 2 | 26584636 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24101472 | ||
| Pubmed | Age-Associated Increase in BMP Signaling Inhibits Hippocampal Neurogenesis. | 1.34e-05 | 3 | 74 | 2 | 25538007 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17047094 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 24048844 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 34208315 | ||
| Pubmed | Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. | 1.34e-05 | 3 | 74 | 2 | 9480811 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 15673568 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 9952395 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 30411342 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 21281598 | ||
| Pubmed | Expression of bone morphogenetic protein receptors in the developing mouse metanephros. | 1.34e-05 | 3 | 74 | 2 | 11701996 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.17e-05 | 473 | 74 | 7 | chr17q21 | |
| Cytoband | 17q21 | 1.49e-04 | 63 | 74 | 3 | 17q21 | |
| Cytoband | 17q21.3 | 3.03e-04 | 16 | 74 | 2 | 17q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.92e-03 | 325 | 74 | 4 | chr9q34 | |
| Cytoband | 19q13.2 | 2.41e-03 | 164 | 74 | 3 | 19q13.2 | |
| Cytoband | 9q34.11 | 3.35e-03 | 53 | 74 | 2 | 9q34.11 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.61e-05 | 22 | 48 | 3 | 579 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 1.44e-04 | 7 | 48 | 2 | 345 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.44e-04 | 7 | 48 | 2 | 1201 | |
| GeneFamily | NME/NM23 family | 2.46e-04 | 9 | 48 | 2 | 961 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.40e-03 | 21 | 48 | 2 | 89 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.67e-03 | 34 | 48 | 2 | 487 | |
| Coexpression | HOOI_ST7_TARGETS_DN | 1.88e-05 | 115 | 74 | 5 | M14801 | |
| Coexpression | GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN | 2.08e-05 | 198 | 74 | 6 | M7605 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 3.81e-07 | 171 | 73 | 6 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 191 | 73 | 6 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 3653002c805c314043e2a7b0c9980dfe952dc53e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-07 | 200 | 73 | 6 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-07 | 200 | 73 | 6 | e0a003d2a5fd6adfcb817c9bc5dceb9c79e7491b | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-06 | 166 | 73 | 5 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.38e-06 | 172 | 73 | 5 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.38e-06 | 172 | 73 | 5 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 184 | 73 | 5 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 184 | 73 | 5 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | 87d4323a72e96ce35f9981faa92ded846a474384 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-05 | 187 | 73 | 5 | b0768a0102d533bc6c9efe56b7a9c18db7a374b7 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.44e-05 | 188 | 73 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 188 | 73 | 5 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 188 | 73 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 1.44e-05 | 188 | 73 | 5 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 188 | 73 | 5 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.52e-05 | 190 | 73 | 5 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 192 | 73 | 5 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 192 | 73 | 5 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.63e-05 | 193 | 73 | 5 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-05 | 193 | 73 | 5 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 194 | 73 | 5 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 194 | 73 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 194 | 73 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.68e-05 | 194 | 73 | 5 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.72e-05 | 195 | 73 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 195 | 73 | 5 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-05 | 195 | 73 | 5 | f1cbf82484f489fe7e0b5de6a49ea28d69f04e1a | |
| ToppCell | proximal-Endothelial-Capillary_Aerocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-05 | 195 | 73 | 5 | 13168c9632b58dd65ecb365df3832d95e7325919 | |
| ToppCell | proximal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.72e-05 | 195 | 73 | 5 | 36b2e754ed7ff138ac05fb51f4494e5339669828 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.72e-05 | 195 | 73 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 195 | 73 | 5 | 58b769da05a8f6b05aeb08d4f8b112941087ad00 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.76e-05 | 196 | 73 | 5 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 196 | 73 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.80e-05 | 197 | 73 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 198 | 73 | 5 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | ASK428-Endothelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.85e-05 | 198 | 73 | 5 | d69d0ff115298596173a4278897a65007a71f5df | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-05 | 199 | 73 | 5 | 1621ce2968f3100e4c39e0ef8293232a5d76c614 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | distal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | e12598a097dd9c4cbf9bb85bfa3057722ef73ad5 | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.94e-05 | 200 | 73 | 5 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.94e-05 | 200 | 73 | 5 | d36236c7703b759309c8347f44900fc4bed377f0 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | 891a80cbde575f81f3466217175f41e1d4f66d5e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | c761d1742653a83e69e4c03d6e10e5e53f28bebb | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_2-C1R--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.94e-05 | 200 | 73 | 5 | dcbc91ed3351bafd72cf71d7025cbbdc8361d9b9 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-05 | 143 | 73 | 4 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.08e-04 | 150 | 73 | 4 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-04 | 158 | 73 | 4 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-04 | 161 | 73 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 1.63e-04 | 167 | 73 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.75e-04 | 170 | 73 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-04 | 170 | 73 | 4 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-04 | 172 | 73 | 4 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 172 | 73 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 172 | 73 | 4 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 172 | 73 | 4 | 94093d356b0252b440deda4e1b0ac332b31513f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 172 | 73 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 172 | 73 | 4 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 175 | 73 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 176 | 73 | 4 | 218a072882d387adbbad6916d7214099c7354465 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 176 | 73 | 4 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 178 | 73 | 4 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 178 | 73 | 4 | 375156ba1c7b8592bf733c75f24968161f7cfa09 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 178 | 73 | 4 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | IIH-matDC|IIH / Condition, Cell_class and T cell subcluster | 2.13e-04 | 179 | 73 | 4 | 5999c85ce3bab5309ff1ed154be7e32b037750b1 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-04 | 179 | 73 | 4 | 228d12ed1c8dc92aefbcea4aaf7d108783c22be0 | |
| ToppCell | IIH-matDC-|IIH / Condition, Cell_class and T cell subcluster | 2.13e-04 | 179 | 73 | 4 | 46074b2781ed79e2979428b3ec81504621d3903c | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.17e-04 | 180 | 73 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-04 | 180 | 73 | 4 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.22e-04 | 181 | 73 | 4 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-04 | 181 | 73 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 181 | 73 | 4 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.22e-04 | 181 | 73 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 181 | 73 | 4 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 182 | 73 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 182 | 73 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.27e-04 | 182 | 73 | 4 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-04 | 183 | 73 | 4 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 183 | 73 | 4 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 183 | 73 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.32e-04 | 183 | 73 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 2.36e-04 | 184 | 73 | 4 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 2.36e-04 | 184 | 73 | 4 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.41e-04 | 185 | 73 | 4 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 2.41e-04 | 185 | 73 | 4 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 2.46e-04 | 186 | 73 | 4 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-04 | 187 | 73 | 4 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| Drug | 3'-AMP | 1.26e-07 | 72 | 74 | 6 | CID000041211 | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.62e-07 | 198 | 74 | 8 | 1299_DN | |
| Drug | AC1Q4Q30 | 2.73e-06 | 9 | 74 | 3 | CID000185818 | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Up 200; 10.2uM; HL60; HT_HG-U133A | 3.36e-06 | 195 | 74 | 7 | 2394_UP | |
| Drug | adenosine 5'-phosphoselenate | 1.04e-05 | 2 | 74 | 2 | CID000440758 | |
| Drug | beta-methylene-APS | 1.04e-05 | 2 | 74 | 2 | CID000129324 | |
| Drug | Nifurthiazole | 1.46e-05 | 15 | 74 | 3 | CID003607071 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-05 | 173 | 74 | 6 | 4565_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.84e-05 | 182 | 74 | 6 | 1891_DN | |
| Drug | U-320 | 3.12e-05 | 3 | 74 | 2 | CID000077162 | |
| Drug | Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A | 4.06e-05 | 194 | 74 | 6 | 1547_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A | 4.67e-05 | 199 | 74 | 6 | 3759_UP | |
| Drug | digalactosyldiacylglycerol (DGDG | 5.57e-05 | 23 | 74 | 3 | CID000447899 | |
| Drug | n-propylbenzene | 6.23e-05 | 4 | 74 | 2 | ctd:C024268 | |
| Drug | SF-6,5 | 6.23e-05 | 4 | 74 | 2 | CID000126860 | |
| Disease | teratoma (is_implicated_in) | 5.52e-05 | 5 | 70 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | nucleoside diphosphate kinase B measurement | 1.16e-04 | 7 | 70 | 2 | EFO_0020615 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.54e-04 | 8 | 70 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.54e-04 | 8 | 70 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | Gastric Adenocarcinoma | 1.69e-04 | 45 | 70 | 3 | C0278701 | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 2.47e-04 | 10 | 70 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | opioid dependence | 2.54e-04 | 237 | 70 | 5 | EFO_0005611 | |
| Disease | vascular dementia (is_marker_for) | 3.01e-04 | 11 | 70 | 2 | DOID:8725 (is_marker_for) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 4.25e-04 | 13 | 70 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | alcohol use disorder (is_implicated_in) | 6.52e-04 | 16 | 70 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Eye Abnormalities | 7.37e-04 | 17 | 70 | 2 | C0015393 | |
| Disease | nicotine dependence symptom count, depressive symptom measurement | 7.64e-04 | 75 | 70 | 3 | EFO_0007006, EFO_0009262 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 1.13e-03 | 21 | 70 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 1.70e-03 | 99 | 70 | 3 | DOID:11446 (biomarker_via_orthology) | |
| Disease | visuospatial function measurement | 1.74e-03 | 26 | 70 | 2 | EFO_0803533 | |
| Disease | Adenoid Cystic Carcinoma | 1.75e-03 | 100 | 70 | 3 | C0010606 | |
| Disease | transforming growth factor beta measurement | 1.87e-03 | 27 | 70 | 2 | EFO_0004818 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.02e-03 | 28 | 70 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | Barrett's esophagus | 2.02e-03 | 28 | 70 | 2 | EFO_0000280 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.13e-03 | 107 | 70 | 3 | DOID:11054 (is_marker_for) | |
| Disease | Epileptic encephalopathy | 2.31e-03 | 30 | 70 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGAKHRWMMEGQRGA | 241 | Q66K41 | |
| MWQAGQRHGPGVMVT | 486 | Q60I27 | |
| GTGRVVMWKMGIRNS | 516 | Q8NEM8 | |
| MAQMGVGEGKSIGEW | 131 | Q8WYN0 | |
| EIVDGNVKMTLGMIW | 121 | P35609 | |
| LPGGNEIGMVAWKMT | 1651 | Q13085 | |
| GIKWPQTQRGMMVER | 476 | O95490 | |
| MVKQIGKGRYGEVWM | 206 | O00238 | |
| ESGNVGTEMMDNRIW | 841 | Q8WUJ3 | |
| SIGQWQKVMEAMGVL | 801 | Q9HCE9 | |
| IGSRMLQAMGWKEGS | 861 | P98175 | |
| MAVEGGIMGIQVNWD | 246 | Q99571 | |
| MVWEGLNVVKTGRVM | 76 | P22392 | |
| IKMVMESGDWLVGGD | 356 | O95340 | |
| KACQMIMGSWNPVGV | 341 | Q3ZCV2 | |
| MQRNGVTKLMDGAFW | 246 | Q6UXM1 | |
| AGGWMLKMTQTQEQD | 2411 | Q8NDA2 | |
| MKWLGESKNMVVNGR | 1 | Q4FZB7 | |
| MGGWEMIRKIGDTSV | 466 | P20700 | |
| GMVCGQNWGIVEAMV | 461 | Q9Y4K0 | |
| TGKLMEGMQVLEWNG | 4546 | Q9Y6V0 | |
| SSRMSWGIQQALVGM | 136 | P47883 | |
| MVLMQDKGSSQQWPG | 1 | P09131 | |
| IGNKMLQAMGWREGS | 746 | P52756 | |
| AMGQGRVAHMIEWQG | 76 | Q86XD5 | |
| TVMVRVGGGWMALDE | 7166 | Q9UPN3 | |
| IKMVMEQGDWLIGGD | 366 | O43252 | |
| WLENSGVSEVNGMMK | 2491 | Q13315 | |
| DGAWGEGQNMLMILK | 161 | O95704 | |
| MMNTGDVGARFKWDI | 4551 | Q4G0P3 | |
| GSVMVIGGIIWSMCQ | 41 | Q8WZ55 | |
| KGDSGGQGLWVTMKM | 371 | Q92608 | |
| GQGLWVTMKMLVGDI | 376 | Q92608 | |
| TGMMTEAEGEKWGLV | 441 | Q9Y6W3 | |
| AWDMPRIMFGAKGQV | 411 | Q9HCG7 | |
| IGEKWDRQGENGQMM | 2351 | P02751 | |
| VEMAEGSNGNKWEMI | 601 | Q9Y2H6 | |
| MVRQVGKGRYGEVWM | 236 | P36894 | |
| EGTGRVVMWRMGILN | 611 | Q5U5Z8 | |
| GNGRWMLTLAKNMEV | 376 | P09543 | |
| WGHQGMVNPTEEGMR | 61 | P78329 | |
| LGKMIMQGGFSVWIG | 691 | P10911 | |
| MVNDRWKTMGGAAQL | 1 | Q8N539 | |
| MNTGAWVNHGRGMVK | 296 | Q6P995 | |
| MKLGTVERRGAMGIW | 536 | Q9Y4G2 | |
| AAVWMQGRVVMADRG | 56 | Q96E14 | |
| SMRQGGMGVWKIIAP | 166 | Q9GZN6 | |
| MVWEGLNVVKTGRVM | 76 | P15531 | |
| MVWEGLNVVKTGRVM | 61 | O60361 | |
| MQVDMSHVLGGQWGG | 756 | Q9UPS6 | |
| NDVMLKTGIGVIRMW | 261 | Q8NC67 | |
| WILKVMNFTVDGMGN | 56 | Q96LD1 | |
| ERLVVTGRAGWMGMG | 6 | Q96B86 | |
| VWGMQTRAVQGMLDF | 501 | P53396 | |
| MMQWVRTQKPGESGI | 276 | Q63HM9 | |
| MGAQGAQESIKAMWR | 1 | Q96DA0 | |
| WMMDIATQREGNSGG | 66 | Q9UK11 | |
| SGGVMATQWQVVGMT | 466 | Q96K58 | |
| WMNMGGIQHIKGKYV | 826 | Q8IUR5 | |
| WMDGQLVEKGRQDMR | 141 | Q9UNW1 | |
| TMVNVGMNDQVWGIG | 336 | Q7Z6L1 | |
| RTVQGMAQGMAWTGQ | 151 | O00624 | |
| LQIGDKIMQVNGWDM | 71 | O14907 | |
| MTWNQMNLGATLKGV | 236 | P19544 | |
| MGTWMGLLNNKVGTF | 591 | O94885 | |
| VGTNMGWADAMAKVL | 86 | Q9Y3B9 | |
| LTGNQGIEAAMDWLM | 26 | Q04323 | |
| WMMETATQREGNLGG | 66 | Q9UK10 | |
| GDRVMVLNRSGMWQE | 131 | Q99536 | |
| NSERMVTVGRWAKGM | 231 | Q8N567 | |
| GVTKEMQTLMGVRWG | 606 | Q8N5H7 | |
| WMMKTAIQREGNSGD | 66 | Q9NZL3 | |
| VLMRKMGWREGEGLG | 2311 | P18583 | |
| ERGMMKGGNKQEEAW | 1186 | Q8NDV7 | |
| NGTWNGMIGEVVMKR | 491 | Q13224 | |
| KEWNGMMGELLSGQA | 496 | Q05586 |